Literature DB >> 19576852

Hit finding: towards 'smarter' approaches.

Thierry Langer1, Rémy Hoffmann, Sharon Bryant, Brigitte Lesur.   

Abstract

Drug discovery is complex and risky, and the chances of success are low. One starting point to discover a new drug is the selective screening of a collection of high value and good quality compounds. Selection of compounds for screening is one of the challenging initial steps in the drug discovery process and is crucial for the success of the project. Optimal selection will enhance the chances of successful hit finding with regard to both number and quality of hits. Several scenarios for compound selection can be envisaged, and are primarily driven by knowledge of the target. Deciding the most appropriate scenario is important and appropriate software packages and chemoinformatics tools are available for these purposes. After screening, researchers may face challenges in selecting the best hits for further optimization. Numerous chemoinformatics tools have emerged recently to address challenges in hit analysis, prioritization and optimization.

Mesh:

Substances:

Year:  2009        PMID: 19576852     DOI: 10.1016/j.coph.2009.06.001

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  5 in total

Review 1.  Designing antimicrobial peptides: form follows function.

Authors:  Christopher D Fjell; Jan A Hiss; Robert E W Hancock; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2011-12-16       Impact factor: 84.694

Review 2.  Modelling three-dimensional protein structures for applications in drug design.

Authors:  Tobias Schmidt; Andreas Bergner; Torsten Schwede
Journal:  Drug Discov Today       Date:  2013-11-08       Impact factor: 7.851

3.  Novel antifungal drug discovery based on targeting pathways regulating the fungus-conserved Upc2 transcription factor.

Authors:  Christina Gallo-Ebert; Melissa Donigan; Ilana L Stroke; Robert N Swanson; Melissa T Manners; Jamie Francisco; Geoffrey Toner; Denise Gallagher; Chia-Yu Huang; Scott E Gygax; Maria Webb; Joseph T Nickels
Journal:  Antimicrob Agents Chemother       Date:  2013-10-21       Impact factor: 5.191

4.  When Quality Beats Quantity: Decision Theory, Drug Discovery, and the Reproducibility Crisis.

Authors:  Jack W Scannell; Jim Bosley
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

Review 5.  Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes.

Authors:  Emmanuelle Lautié; Olivier Russo; Pierre Ducrot; Jean A Boutin
Journal:  Front Pharmacol       Date:  2020-04-07       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.